Discovery Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2025

Key Benefits of the Discovery Stage Partnering Terms and Agreements in Pharma and Biotech Report

 

✔ Unparalleled Market Insights – Gain an in-depth understanding of discovery-stage deal trends shaping the pharma and biotech industry since 2020.

✔ Financial Data Access – Unlock headline values, upfront payments, milestone structures, and royalty terms, giving you a competitive edge in deal negotiations.

✔ Comprehensive Deal Database – Access a curated repository of over 2,690 discovery-stage agreements, including contract documents where available, for unmatched transparency and benchmarking.

✔ Deep-Dive into Industry Leaders – Analyze actual discovery-stage deals entered into by the top 25 global pharma and biotech companies, alongside emerging biopharma players.

✔ Proven Case Studies & Structural Analysis – Examine real-world deal structures and case studies to refine your own partnering and negotiation strategies.

✔ High-Value Deal Identification – Pinpoint the most lucrative discovery-stage deals since 2020, gaining insight into premium industry transactions.

✔ Profile the Most Active Dealmakers – Identify the key players driving discovery-stage collaborations, ensuring you target the right partners.

✔ Strategic Deal Mapping – Navigate a full A-Z listing of discovery-stage agreements, categorized by company, development phase, deal type, therapeutic area, and technology focus.

✔ Negotiate with Confidence – Understand the key terms and conditions top-tier companies have agreed to in previous deals, helping you structure optimal agreements.

✔ Robust Due Diligence Support – Conduct data-backed assessments to determine the viability and competitiveness of your proposed deal terms with potential partners.

 

This report is your ultimate resource for discovery-stage partnering intelligence—providing the critical data and insights needed to secure high-value partnerships with confidence.

Executive Summary

               

Chapter 1 – Introduction

 

Chapter 2 – Why do companies partner at discovery stage?

2.1. Introduction

2.2. The role of discovery stage partnering

2.2.1. In-licensing at discovery stage

2.2.2. Out-licensing at discovery stage

2.3. Difference between discovery, preclinical and clinical stage deals

2.4. Reasons for entering into discovery stage partnering deals

2.4.1. Licensors reasons for entering discovery stage deals

2.4.2. Licensees reasons for entering discovery stage deals

2.5. The future of discovery stage partnering deals

 

Chapter 3 – Discovery stage deal strategies and structure

3.1. Introduction

3.2. At what stage do companies partner?

3.2.1. Partnering early in pharmaceutical/biotech

3.2.1.1. Discovery and preclinical stage partnering case studies

3.2.1.1.a. Case study 1

3.2.1.1.b. Case study 2

3.2.1.1.c. Case study 3

3.2.1.1.d. Case study 4

3.2.2. Partnering later in pharmaceutical/biotech

3.2.2.1. Clinical stage partnering case studies

3.2.2.1.a. Case study 5

3.2.2.1.b. Case study 6

3.2.2.1.c. Case study 7

3.2.2.1.d. Case study 8

3.3. Early and later stage partnering – a risk/cost comparison

3.4. What do companies spend on discovery, preclinical and clinical stage partnering?

3.5. Pure versus multi-component partnering deals

3.6. Pure licensing agreement structure

3.6.1. Example pure licensing agreements

3.6.1.a. Case study 9

3.6.1.b. Case study 10

3.7. Multicomponent discovery stage partnering agreements

3.7.1.a. Example multicomponent early stage clauses

3.7.1.a. Case study 11

3.7.1.b. Case study 12

 

Chapter 4 – Discovery stage partnering payment strategies

4.1. Introduction

4.2. Discovery stage payment strategies

4.3. Payment options

4.3.1. Headline values

4.3.2. Upfront payments

4.3.2.1. Conditionality of upfront payments

4.3.3. Loans

4.3.4. Convertible loans

4.3.5. Equity

4.3.6. R&D funding

4.3.7. Licensing fees

4.3.8. Milestone payments

4.3.9. Royalty payments

4.3.9.1. Issues affecting royalty rates

4.3.9.2. Royalties on combination products

4.3.9.2.a. Case study 13

4.3.9.3. Guaranteed minimum/maximum annual payments

4.3.9.4. Royalty stacking

4.3.9.5. Royalties and supply/purchase contracts

4.3.10. Quids

4.3.11. Option payments

 

Chapter 5 – Trends in discovery stage deal making

5.1. Introduction

5.2. Discovery stage partnering over the years

5.2.1. Attributes of discovery deals

5.3. Discovery stage partnering by deal type

5.4. Discovery stage partnering by disease type

5.5. Partnering by discovery stage technology type

5.6. Discovery stage partnering by most active company, 2020 to 2025

 

Chapter 6 – Payment terms for discovery stage partnering

6.1. Introduction

6.2. Guidelines for discovery stage payment terms

6.2.1. Upfront payments

6.2.2. Milestone payments

6.2.3. Royalty payments

6.3. Discovery stage payment terms – deal data analysis

6.3.1. Public data

6.3.2. Survey data

6.4. Payment terms analysis

6.4.1. Discovery stage headline values

6.4.2. Discovery stage deal upfront payments

6.4.3. Discovery stage deal milestone payments

6.4.4. Discovery stage royalty rates

 

Chapter 7 – Leading discovery stage deals

7.1. Introduction

7.2. Top discovery stage deals by value

 

Chapter 8 – Top 25 most active discovery stage dealmakers

8.1. Introduction

8.2. Top 25 most active discovery stage dealmakers

 

Chapter 9 – Discovery stage partnering contracts directory

9.1. Introduction

9.2. Discovery stage deals with contracts 2020 to 2025

 

Chapter 10 – Discovery stage deal making by development stage

 

10.1. Introduction

10.2. Deals by discovery stage

 

 

Appendices

                                   

Appendix 1 – Discovery stage dealmaking by companies A-Z

Appendix 2 – Discovery stage dealmaking by industry sector

Appendix 3 – Discovery stage dealmaking by stage of development

Appendix 4 – Discovery stage dealmaking by therapy area

Appendix 5 – Discovery stage dealmaking by technology type

 

About Biopharma Research Ltd

 

Current Partnering

Current Agreements

Recent report titles from Current Partnering

 

Table of figures

 

Figure 1: Definition of discovery, preclinical and clinical phases in dealmaking

Figure 3: Components of the pure licensing deal structure

Figure 4: Payment options for discovery stage partnering deals

Figure 5: Issues affecting royalty rates   

Figure 6: Discovery stage partnering frequency 2020 - 2025      

Figure 7: Discovery stage partnering by deal type since 2020     

Figure 8: Discovery stage partnering by disease type since 2020

Figure 9: Discovery stage partnering by technology type since 2020       

Figure 10: Top 25 most active discovery stage dealmakers, 2020 to 2025

Figure 11: Review of median upfront payments for discovery stage deals

Figure 12: Review of median milestone payments for discovery stage deals        

Figure 13: Review of median royalty payments for discovery stage deals 

Figure 14: Discovery stage deals with a headline value  

Figure 15: Discovery stage deals with an upfront value   

Figure 16: Discovery stage deals with a milestone value 

Figure 17: Discovery stage deals with a royalty rate value           

Figure 18: Top discovery stage deals by deal value since 2020   

Figure 19: Most active discovery stage dealmakers 2020 to 2025

Pricing options

• $4995: Single-user
• $6995: Multi-user (2-5 users)
• $8995: Corporate (unencrypted PDF)

 

A full explanation of license type definitions can be found here.

 

Our guarantee

 

Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.

 

Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.

 

Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

 

Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.

 

Total Trust

Current Partnering is part of Biopharma Research Ltd., based in York, United Kingdom. We have been trading successfully online since 2012 and work with some of the most famous brands in the business. We carefully select our partners to ensure that the publications meet expectations of demanding customers.

2seventy bio, 3B Pharmaceuticals, 3T Biosciences, 3Z, 4basebio Discovery, 4B Technologies, 4D Molecular Therapeutics, 4P-Pharma, 7 Hills Pharma, 10X Genomics, 23andMe, 48Hour Discovery, 65LAB, 221b Foundation, 858 Therapeutics, 1910 Genetics, A*STAR Agency for Science, Technology and Research, A*STAR Bioprocessing Technology Institute, A*STAR Singapore Immunology Network, A*STAR’ Institute of Molecular and Cell Biology, A2A Pharmaceuticals, Aachen University, Aarhus University, Aarvik Therapeutics, AavantiBio, AAVnerGene, Abbisko Therapeutics, Abbvie, Abcam, AbCellera Biologics, AbCheck, Abera Bioscience, Abilita Bio, Abilita Therapeutics, Abintus Bio, Abiosciences, ABL Bio, Ablexis, Ablynx, Ab Magnitude Ventures, Abound Bio, Aboundbio, AbSci, Absolute Antibody, Ab Studio, AbTis, ABVC BioPharma, Abveris, Abzena, ACADIA Pharmaceuticals, AC Bioscience, Accelerate Technologies, Accelerator for Technological Research in Genomic Therapies, Accelero Biostructures, Accent Therapeutics, Accurus Biosciences, Accutar Biotechnology, Acerand Therapeutics, Acerta Pharma, Achilles Therapeutics, AchilleS Vaccines, Aclaris Therapeutics, Acrobat Genomics, ACROBiosystems, Actinium Pharmaceuticals, ACT Therapeutics, Actuate Therapeutics, Acucela, Acuitas Therapeutics, Acurx Pharmaceuticals, Adagene, AdAlta, Adapsyn Bioscience, Adaptimmune, Adaptive Biotechnologies, Adaptive Phage Therapeutics, AdaptVac, Adcendo, Adcentrx Therapeutics, ADC Therapeutics, Addex Therapeutics, Adeptrix, Adicet Bio, Adimab, Adnab, Adolore Biotherapeutics, Adrestia, AdventHealth, Aegis Life, Aelian Biotechnology, Aerogen, Aethlon Medical, Aethon Therapeutics, Affilogic, Affimed Therapeutics, Affini-T Therapeutics, Affinia Therapeutics, Affinity Biosciences, AffyXell Therapeutics, Afrigen Biologics, AGC Biologics, Agenus Bio, AgeX Therapeutics, Agilent Technologies, AHN Autoimmunity Institute, AiCuris, Aignostics, AIkido Pharma, AimedBio, AIM ImmunoTech, Aimmune Therapeutics, Ainnocence, AI Proteins, Aitia, Ajinomoto, Akadeum Life Sciences, Akers Biosciences, Akoya Biosciences, Akshaya Bio, Aktis Oncology, Alamar Biosciences, Albert Einstein College of Medicine, Albumedix, Alchemab, Alchemab Therapeutics, Aldevron, Alexion Pharmaceuticals, Alex’s Lemonade Stand Foundation, AlgenScribe, Aligning Science Against Parkinson’s, Aligos Therapeutics, AlivaMab Discovery Services, ALK-Abello, ALK Positive, Alkyon Therapeutics, All4Cure, Allegheny General Hospital, Allele Biotechnology and Pharmaceuticals, Allen Institute for Brain Science, Allen Institute for Immunology, Allergan, Alliance for Cancer Gene Therapy, Alligator Bioscience, Allogene Overland Biopharm, Allogene Therapeutics, Alloplex Biotherapeutics, Allosteric Bioscience, Alloy Therapeutics, Allozymes, Almac Discovery, Almirall, Alnylam Pharmaceuticals, Alpenglow Biosciences, ALPHA10X, Alpha Biopharma, Alpha Cancer Technologies, Alphageneron Pharmaceuticals, Alpha Tau Medical, Alpine Immune Sciences, Altamira Therapeutics, Alterity Therapeutics, Alveo Technologies, ALX Oncology, Alyatec, Alytas Therapeutics, Alzheimer's Drug Discovery Foundation, Alzheimer's Foundation of America, Amagma Therapeutics, Amarna Therapeutics, Amathus Therapeutics, Ambiopharm, American Association for Cancer Research, American Diabetes Association, American Skin Association, American Type Culture Collection (ATCC), Ametek, Amgen, Amicogen, Amicus Therapeutics, AmMax Bio, Amphilix, Amphista Therapeutics, AMRA Medical, Amylyx Pharmaceuticals, Amyris, AN2 Therapeutics, Anagenex, Analog Devices, Analytical BioSciences, Anavo Therapeutics, Anew Medical, Angiogenesis Foundation, Angios, Anima Biotech, Anixa Biosciences, Anji Pharma, Ankarys Therapeutics, Ankyra Therapeutics, Annogen, Antengene, Antibe Therapeutics, Antion Biosciences, Antios Therapeutics, Antiverse, Apellis Pharmaceuticals, Apollo Therapeutics, Appia Bio, Applied Biology, Applied BioMath, Applied DNA Sciences, Applied Genetic Technologies, Applied StemCell, Aprecia Pharmaceuticals, Aptinyx, Aptorum Group, Aqemia, Aqilion, Aquinnah Pharmaceuticals, Aragen Bioscience, Aragen Life Sciences, Araris Biotech, ARase Therapeutics, Aravive Biologics, Arbor Biotechnologies, Arbutus, ARCA Biopharma, ARC Therapeutics, Arctic Vision, Arctoris, Arcturus Therapeutics, Arcus Biosciences, Ardeagen, Ardigen, Arecor, Arena Pharmaceuticals, Ares Genetics, argenx, Argobio, Argonne National Laboratory, Ariana Pharma, Ariceum Therapeutics, Aridis Pharmaceuticals, Ariel Precision Medicine, Arima Genomics, Arizona State University, Arnay Sciences, Aro Biotherapeutics, Arrakis Therapeutics, Arrowhead Pharmaceuticals, Arsenal Biosciences, Artios Pharma, Artisan Bio, Artiva Biotherapeutics, Artizan Biosciences, Arvinas, Arzeda, Ascendis Pharma, Ascidian Therapeutics, ASC Therapeutics, Asieris Pharmaceuticals, ASKA Pharmaceuticals, Asklepios Biopharmaceutical, Aspect Biosystems, Assembly Biosciences, Associazione Poic e Dintorni APS, Astellas Pharma, Astellas Pharma US, Astex Pharmaceuticals, AstraZeneca, Astrogen, AstronauTx, Asylia Therapeutics, ATAI Life Sciences, Atalanta Therapeutics, Atara Biotherapeutics, Atavistik Bio, Athebio, Athenex, Athos Therapeutics, Atlas Venture, Atomwise, ATP, Atreca, ATUM, aTyr Pharma, AUM Biosciences, Auransa, Aurigene Discovery Technologies, Australian Research Council, Australian Research Data Commons, Autifony Therapeutics, Autigen, Autobahn Labs, Autolus, Autotelic BIO, Avacta, AvantGen, Avatamed, Avectas, Aviceda Therapeutics, Avicenna Biosciences, Avidity Biosciences, Avista Therapeutics, Avrobio, Axcelead Drug Discovery Partners, Axial Biotherapeutics, Axis Therapeutics, Axovant Gene Therapies, Axxam, Azenta Life Sciences, Azitra, Azos Bio, BAKX Therapeutics, Barer Institute, Barrow Neurological Institute, Base4 Biotechnology, Battelle, Bayer, Bayer CropScience, Baylor College, Baylor College of Medicine, Baylor Scott and White Research Institute, BC Platforms, Beacon Biosignals, Beacon Discovery, Beactica, Beam Therapeutics, Beartooth Therapeutics, BehaVR, Beiersdorf, BeiGene, Beijing Genomics Institute (BGI), Beijing Illness Challenge Foundation, Beijing Tide Pharmaceutical, Beijing University of Chinese Medicine, Belharra Therapeutics, Bellicum Pharmaceuticals, Benaroya Research Institute, BenevolentAI, Berg, Berkeley Lights, Beroni Group, Berry Genomics, Be The Match BioTherapies, Beth Israel Deaconess Medical Center, Bethyl Laboratories, BGN Technologies, Bharat Biotech, Bicycle Therapeutics, Bielefeld University, BigHat Biosciences, Bill and Melinda Gates Foundation, Binghamton University, Bintai Kinden, Bio-Techne, BioAge Labs, BioArctic AB, biOasis Technologies, BioCardia, BioComo, BioCopy, BiocurePharm, Biocytogen, BioDuro, Biogen, Biognosys, Biohaven Pharmaceuticals, BioInvent, BioKey, BioLite Japan, Biolojic Design, BioMap, BioMarin Pharmaceutical, Biomedical Advanced Research and Development Authority, Biomedical Primate Research Centre, BioMed X Innovation Center, BioMotiv, BiomX, BiondVax, BiOneCure Therapeutics, Bionetix, Bioniz Therapeutics, BioNova Pharmaceuticals, BioNTech, BioPharmics, Bioqube Ventures, Biorchestra, Biortus Biosciences, Biosceptre International, Biosion, Biositu Pharmaceutical Technology, BioSkryb, BioSpherix, BioStrand, BioSymetrics, BioTheryX, Biotheus, Biotools, Biotx.ai, BioVaxys, BioVersys, BIRAD Research and Development Company, Bird Foundation, Bit Bio, bitBiome, Bitterroot Bio, BiVictriX Therapeutics, Black Diamond Therapeutics, Blacksmith Medicines, Bloom Science, Blu Biotech, Bluebird Bio, Bluebridge Technologies, Blue Diamond Growers, Blue Dolphin Lead Discovery, Blueprint Medicines, BlueRock Therapeutics, Boca Biolistics, Boehringer Ingelheim, Boehringer Ingelheim Vetmedica, Bohai Biomedical, Bolder BioPATH, Bolt Biotherapeutics, Boostimmune, Boragen, BostonGene, Boston University, BPGbio, Bracco Imaging, BRAIN Biotech, Brain Canada, BrainXell, BravoVax, Breakthrough Health, BriaCell Therapeutics, Brickell Biotech, BridgeBio Pharma, Bridge Biotherapeutics, Bridge Medicines, BridGene Biosciences, Brigham and Women's Hospital, BrightPath Biotherapeutics, Bright Peak Therapeutics, Brightseed, Brii Biosciences, Bristol-Myers Squibb, Broad Institute, Broadwing Bio, Brooklyn ImmunoTherapeutics, Brown University, Burning Rock, BurstIQ, Byondis, C2N Diagnostics, C4 Therapeutics, C4X Discovery, Cabaletta Bio, Calcimedica, Calico, Calidi Biotherapeutics, California Institute for Biomedical Research, California Institute for Regenerative Medicine, California Institute of Technology, Calviri, Calyxt, Cambridge Quantum Computing, Camino Pharma, CAMP4 Therapeutics, Can-Fite BioPharma, CanAm Bioresearch, CANbridge Pharmaceuticals, Cancer Genetics, Cancer Research Horizons, Cancer Research UK, Candid Therapeutics, Cantabio Pharmaceuticals, Cantargia, Capricor Therapeutics, Capsida Biotherapeutics, Capsigen, Captor Therapeutics, Caravan Biologix, Caraway Therapeutics, CARB-X, Cardiff Oncology, Cardiff University, CARE, Care4Rare Consortium, Caribou Biosciences, Carina Biotech, Caris Life Sciences, Carisma Therapeutics, Carmine Therapeutics, Carna BioSciences, Carterra, Cartexell, Casdin Capital, Case Western Reserve University, Casma Therapeutics, Castle Creek Biosciences, CasZyme, Catalent, Catamaran Bio, Catholic University Leuven, CDR-Life, Ceapro, Cedars-Sinai Medical Center, Cedilla Therapeutics, Celdara Medical, CelerisTx, Celgene, Cell&Soft, Cell and Gene Therapy Catapult, Cellaria Biosciences, Cellarity, Cellectis, Cellectricon, Cellerant Therapeutics, Cellerys, Cellevolve Bio, Cellinfinity Bio, Cellkey, Cell Mogrify, CellOrigin Biotech, Cellscript, Cell Signaling Technology, Cellular Biomedicine, Celonic, Celsius Therapeutics, Celularity, Center for Biomarker Research in Medicine, Center for Genomic Regulation, Centessa Pharmaceuticals, Centogene, Centre for Commercialization of Cancer Immunotherapy and Regenerative Medicine, Centre for Commercialization of Regenerative Medicine (CCRM), Centre Leon Berard, Century Therapeutics, Cerebras Systems, Cerecin, Cerecor, Cerevance, Cerevel Therapeutics, CERo Therapeutics, Certara, Cerveau Technologies, Cevec Pharmaceuticals, Champions Oncology, Chan Zuckerberg Initiative, Charite Universitatsmedizin Berlin, Charles River Laboratories, CHARM Therapeutics, Chelexa Biosciences, ChemAxon, ChemDiv, Chemical Abstracts Service (CAS), Chemify, Chemspace, Chiesi Farmaceutici, Children's Hospital Boston, Children's Hospital of Philadelphia, Children's Medical Research Institute, Children's Mercy Hospital, Children's National Hospital, Chimeric Therapeutics, Chinese Academy of Sciences, Chinook Therapeutics, Cholesgen, Chonnam National University, CHO Plus, Chroma Medicine, Chugai Pharmaceutical, Cicero Diagnostics, CIC nanoGUNE, CiMaas, Cimeio Therapeutics, Cincinnati Children’s Hospital Medical Center, Circle Pharma, Circuit Clinical, Circular Genomics, Citranvi Biosciences, City of Hope, CK Life Sciences, Clarity Pharmaceuticals, Clarus Therapeutics, Clear Creek Bio, Clearmind Medicine, ClearPoint Neuro, Cleveland Clinic, Clover Biopharmaceuticals, CM Life Sciences, CMT Research Foundation, CN Bio, CNS Pharmaceuticals, Coalition for Epidemic Preparedness Innovations, Coave Therapeutics, Cocrystal Pharma, CODA Biotherapeutics, Codagenix, Code Biotherapeutics, Codex DNA, Codexis, Codiak BioSciences, Coeptis Therapeutics, Cogia Biotech, CogState, CoImmune, Cold Spring Harbor, Collaborations Pharmaceuticals, Collplant, Colombia Ministry of Health and Social Protection, Colorado Center for Personalized Medicine, Colorado State University, Columbia University, Columbia University Medical Center, Combined Therapeutics, Combotope Therapeutics, Comera Life Sciences, Complete Phytochemical Solutions, Complix, Concept Life Sciences, ConcertAI, Concr, Confo Therapeutics, Congruence Therapeutics, Conkwest, ConserV Bioscience, Contera Pharma, Context Therapeutics, Contour Therapeutics, Cornell University, Corteva Agriscience, Covant Therapeutics, Creoptix, CRISPR Therapeutics, Cristal Therapeutics, Critical Path Institute (C-Path), Crohn's and Colitis Foundation of America, Crown Bioscience, CSIRO, CSL, CSL Behring, CStone Pharmaceuticals, CtM Biotech, Cue Biopharma, Cullgen, Cullinan Oncology, Curadev Pharma, Curadigm, Curasan, Curasight, Cure Duchenne, Cure Genetics, Curetis, CureVac, Curia, Curiox Biosystems, Curreio, CVC, CvergenX, Cybin, Cyclenium Pharma, Cyclerion Therapeutics, Cyclica, Cyclo Therapeutics, CYduct Diagnostics, Cyrus Biotechnology, Cystic Fibrosis Foundation, cytena, Cytocom, CytoImmune Therapeutics, CytoLynx Therapeutics, CytoMed Therapeutics, CytomX Therapeutics, Cytoo, CytoReason, Cytosurge, Cytovance Biologics, CYTOVIA Therapeutics, D-Wave Quantum, D2M, DAAN Bio Therapeutics, Daewoong Pharmaceutical, Daiichi Sankyo, Dalriada Drug Discovery, Dana-Farber Cancer Institute, Dana Farber Partners Cancer Care, Danaher, DanausGT Biotechnology, Dante Labs, Dapu Biotechnology, Dartmouth College, DarwinHealth, Dassault Systems, Day One Biopharmaceuticals, DayTwo, Debiopharm, Decibel Therapeutics, deCODE Genetics, DeepCDR Biologics, Deepcell, Deep Genomics, Deep Longevity, Deerfield Management, Defense Advanced Research Projects Agency, Defense Threat Reduction Agency, Delix Therapeutics, Delta 4, Dementia Research Institute, Denali Therapeutics, Denovium, Department of Defence, Department of Defense, DevsHealth, Dewpoint Therapeutics, Diagnostic Biochips, Diagnostic Robotics, Diamond Light Source, DiNAQOR, DIOSynVax, Discngine, Distributed Bio, DNAnexus, DNA Script, DNX Biopharmaceuticals, doc.ai, Domainex, Door Pharmaceuticals, Dorian Therapeutics, DotBio, Dotmatics, Dragonfly Therapeutics, Dren Bio, Drexel University, DualityBio, Dualsystems Biotech, Duke-NUS Graduate Medical School Singapore, Duke University, Dunad Therapeutics, DuPont Pharmaceuticals, Dyadic International, DyNAbind, Dynavax Technologies, Dyno Therapeutics, DYO Biotechnologies, E.T. Horn, Eagle Genomics, Eberhard Karls University Tubingen, Edesa Biotech, EdiGene, EDIRNA, Edison Oncology, Editas Medicine, EditForce, eFFECTOR Therapeutics, Egle Therapeutics, Eikonizo Therapeutics, Eikonoklastes Therapeutics, Eisai, Elaaj Bio, Elanco, Elasmogen, Element Biosciences, ElevateBio, Elevation Oncology, Eleven Biotherapeutics, Elicio Therapeutics, Eligo Bioscience, Eli Lilly, Elix, Elixirgen, Elpiscience, Elsie Biotechnologies, Elysium Health, Embark Biotech, Emendo Biotherapeutics, Emergence Therapeutics, Emergent BioSolutions, Emergex Vaccines, Emory University, Empirico, Enamine, Enara Bio, Endevica Bio, Engitix, Enigma Biomedical, Enleofen Bio, ENPICOM, Ensoma, Enterprise Ireland, Enveric Biosciences, Envisagenics, Enzolytics, EpiAxis Therapeutics, Epic Sciences, Epidemiologic Solutions, EpimAb Biotherapeutics, EpiPharma, Epivax, EpiVax Therapeutics, EQRx, Equillium, Eracal Therapeutics, Erasmus University Medical Center, ERS Genomics, Ervaxx, ErVimmune, Escugen, EsoCap, Esperovax, Estee Lauder, Eterna Therapeutics, eTheRNA immunotherapies, Ethos Discovery, Ethris, ETH Zurich, Eucure Biopharma, Eureka Eurostars, Eureka Therapeutics, Eurocine Vaccines, Eurofins Discovery, European Investment Bank, European Molecular Biology Laboratory, European Union, European Union Regional Development Fund, Eutilex, Evaxion Biotech, EV Biologics, Evercyte, Everest Medicines, Evergreen Theragnostics, EVerZom, Evitria, Evive Biotechnology, EvolveImmune Therapeutics, Evommune, Evonetix, Evopoint Biosciences, EVOQ Therapeutics, Evotec, Evox Therapeutics, Evozyne, EVQLV, Evrys Bio, Exacis Biotherapeutics, Exact Sciences, Exagen Diagnostics, ExcellGene, ExCellThera, Excelra, Exelixis, ExeVir Bio, Exicure, Expansion Therapeutics, Experimental Drug Development Centre, Experimental Therapeutics Centre of Singapore, Exploit Technologies, ExpreS2ion Biotechnologies, Expressive Neuroscience, Exscientia, Eyam Vaccines and Immunotherapeutics, F-Star Therapeutics, Facial Pain Research Foundation, Facio Therapies, Factor Bioscience, FairJourney Biologics, Fannin, FAR Biotech, Fate Therapeutics, FatiAbGen, Fauna Bio, Federation Bio, Feinstein Institute for Medical Research, Ferring Pharmaceuticals, FibroBiologics, Fibrogen, FibroGenesis, FightMND, Filament Health, Finch Therapeutics, FineImmune Biotechnology, FINGERS Brain Health Institute, Five Prime Therapeutics, Flagship Biosciences, Flagship Pioneering, Flamingo Therapeutics, Flare Therapeutics, Flatiron Health, Florabio, Florica Therapeutics, Florida Atlantic University Research, Florida International University, Flow Eighteen38, Fluidigm, Foghorn Therapeutics, Fondazione Telethon, Food and Drug Administration (FDA), Forcefield Therapeutics, Form Bio, FortySix Venture Capital, Fosun Pharmaceutical, Foundation for Neglected Disease Research, Foundation for Sarcoidosis Research, Foundation Medicine, Foundation to Fight H-ABC, Foundery Innovations, FOXG1 Research Foundation, FOXO BioScience, Frame Cancer Therapeutics, Frametact, Fraunhofer Institute for Molecular Ecology (IME), Frederick National Laboratory For Cancer Research, Fred Hutchinson Cancer Research Center, Freeline Therapeutics, FreeMind Group, Friends of FSH Research, Frontier Medicines, FUJIFILM Cellular Dynamics, Fujifilm Diosynth Biotechnologies, Fujitsu Laboratories, Fulcrum Therapeutics, Fundacion Progreso y Salud, Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Fusion Pharmaceuticals, FuturaGene, FutureGen Biopharm, Fuzionaire, Fuzionaire Diagnostics, G1 Therapeutics, Gabriella Miller Kids First Data Resource Center, Gadeta, Gaeta Therapeutics, Gain Therapeutics, Galapagos, Gallant Therapeutics, Gandeeva Therapeutics, GATC Health, GC Biopharma, GC Pharma, Gedeon Richter, GE Healthcare, Geisinger Health System, Gemini Therapeutics, GEMoaB, GEn1E Lifesciences, GeneCentric Therapeutics, Genechem, GeneCode, GenEdit, Genentech, GeneQuantum Healthcare, General Automation Lab Technologies, Generate Biomedicines, Generation Bio, Generation Biotech, Generex Biotechnology, Generian Pharmaceuticals, Genesis Therapeutics, Genethon, Genetic Leap, Genetics Research, Genevant Sciences, GenFleet Therapeutics, Genialis, GenKOre, Genmab, Gennao Bio, Genocea Biosciences, Genome and Company, Genome Biologics, Genome Insight, Genome Institute of Singapore, Genomenon, Genomic Biopharma, Genomics England, Genosity, Genovis, Genprex, Gensaic, GenScript Biotech, GenScript ProBio, GentiBio, Genuity Science, Genzyme, George Mason University, Georgetown University, GeoVax, German Cancer Research Center, German Federal Ministry of Education and Research, Gero, Gicell, Gigagen, GigaMune, GI Innovation, Gilbert Family Foundation, Gilead Sciences, Gilgamesh Pharmaceuticals, Ginkgo BioWorks, Gladstone Institutes, GlamorousAI, Glenmark Pharmaceuticals, Global Alzheimer's Platform (GAP), GlobalBio, Global Cancer Technology, Global Genes, Global Virus Network, GlycoMantra, GlycoNet, Glycotope Biotechnology, GlycoT Therapeutics, Glykos, GNS Healthcare, Goethe University Frankfurt, Goldfinch Bio, GondolaBio, Google, Gossamer Bio, GO Therapeutics, Government of Hong Kong, Government of Ireland, Government of South Korea, Gracell Biotechnologies, Graviton Bioscience, Gray Matter, Greenlight Biosciences, Grid Therapeutics, Griffith University, Grifols, Gritstone Bio, Grunenthal, GSK, GT Apeiron Therapeutics, GT Biopharma, Guangzhou Fanen Biotechnology, Guangzhou Institute of Respiratory Disease, Guardant Health, Gubra, Gyroscope Therapeutics, H3 Biomedicine, Hackensack Meridian Health, Hadassah Medical Center, Haihe Laboratory of Cell Ecosystem, Hainan Sinotau Pharmaceutical, Hairy Cell Leukemia Foundation, Halberd, HaloVax, Halozyme Therapeutics, HanAll Biopharma, HanAll Pharmaceuticals, HanchorBio, Hanmi Pharmaceutical, Hannover Medical School, Hansa Biopharma, Harbour Biomed, Harpe Bioherbicide Solutions, Harvard Medical School, Harvard University, HCW Biologics, HDT Bio, Health Holland, Healx, Heartseed, Heat Biologics, HebeCell, Hebrew University of Jerusalem, Helius Medical Technologies, Helmholtz Zentrum Munchen, Helsinn Healthcare, HemoShear, Henlius Biotech, Henry M. Jackson Foundation, HepaTx, Heqet Therapeutics, Hereditary Neuropathy Foundation, Herophilus, HiFiBio, Highlight Therapeutics, HighRes Biosolutions, Hillstream BioPharma, Histogen, Hitachi, HitGen, Hong Kong Polytechnic University, Hong Kong University of Science & Technology, Honor Epic Enterprises, Hopstem Biotechnology, Horizon Discovery, Horizon Europe, Horizon Therapeutics, Hospital for Sick Children, Hospital for Special Surgery, Hoth Therapeutics, HotSpot Therapeutics, Hox Therapeutics, HTG Molecular Diagnostics, Hubrecht Institute, Hudson Institute of Medical Research, Huma, Hummingbird Bioscience, Hummingbird Diagnostics, Hunterian Medicine, Huyabio International, Hybridize Therapeutics, Hyundai Hope On Wheels, I-mab, IAMA Therapeutics, IASO Biotherapeutics, Iaso Therapeutics, iBio, IBM, Icagen, Icahn School of Medicine at Mount Sinai, Ichnos Sciences, Icosagen Group, Icosavax, IDBiologics, IDEAYA Biosciences, iECURE, iGenomix, IGM Biosciences, IIT-Istituto Italiano di Tecnologia, Ikena Oncology, Iksuda Therapeutics, Iktos, Ildong Pharmaceutical, ILiAD Biotechnologies, Illumina, ImaginAb, Imagine Pharmaceuticals, Imec, IMIDomics, Immagene, Immatics Biotechnologies, Immetas Therapeutics, Immix Biopharma, Immorna, ImmPACT Bio, Immunai, ImmuneCyte Life Sciences, Immuneering, Immunitas Therapeutics, ImmunityBio, ImmunoBiochem, ImmunoChina Pharmaceuticals, Immunocore, ImmunoForge, ImmunoGen, Immunome, Immunomic Therapeutics, ImmunoPrecise Antibodies, ImmunoScape, ImmunOs Therapeutics, ImmuPharma, Immuron, Immusoft, Immutep, IMPACT Therapeutics, Imperial College London, Imvaq Therapeutics, In4Derm, INBRAIN Neuroelectronics, Inceptor Bio, Incyte, InDex Pharmaceuticals, Indiana University, Indivumed, Infection Innovation Consortium, Infectious Disease Research Institute (IDRI), Infex Therapeutics, Infinimmune, Inhibrx, Initium Therapeutics, INmune Bio, Innate Pharma, InnDura Therapeutics, INNERVIA Bioelectronics, InnoCentive, InnoRNA, Innosuisse, Innovate UK, Innovent Biologics, Inotrem, Inovio, Inovio Pharmaceuticals, Inozyme Pharma, InProTher, Inserm, Inserm Transfert, Insilico Biotechnology, Insilico Medicine, Insitro, Instem, Institut Bergonie, Institut Carnot CALYM, Institute for Bioscience and Biotechnology Research, Institute for Research in Biomedicine, Institute for Research in Immunology and Cancer – Commercialization of Research, Institute for Systems Biology, Institute of Cancer Research, Institute of Materia Medica, Institute of Molecular and Clinical Ophthalmology Basel, Institute of Neurodegenerative Diseases, Institute of Virology and Immunology, Institut Gustave Roussy, Institut Imagine, Institut Pasteur, Intas Pharmaceuticals, Integral Molecular, Integrated Biosciences, Integrated BioTherapeutics, Integra Therapeutics, Intel, IntelGenx, Intellia Therapeutics, International Center for Genetic Engineering and Biotechnology, International Isotopes, InterVenn, Intima Bioscience, IntoCell, Intravacc, Intrexon, iNtRON Biotechnology, Invasight, InveniAI, Invenra, Inventia Life Science, Inventum Genetics, Invetx, InvisiShield Technologies, Invitae, InxMed, iOncologi, iOnctura, Ionis Pharmaceuticals, IONTAS, Iovance Biotherapeutics, iPrime Therapeutics, iProgen Biotech, Ipsen, IRBM, iSiP, Isomorphic Labs, IsoPlexis, Israeli National Authority for Technological Innovation, Israel Institute for Biological Research, ITM Isotopen Technologien, Itochu, iTolerance, Ixaka, Ix Therapeutics, J2H Biotech, Jacobio Pharmaceuticals, Jaguar Health, James Cook University, James Hutton Institute, Janssen Biotech, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Janssen Research & Development, Janux Therapeutics, Japan Tobacco, Javelin Biotech, Jazz Pharmaceuticals, JCR Pharmaceuticals, Jesse's Journey, Jiangsu Hansoh Pharmaceutical, Jiangsu Hengrui Medicine, Jiangsu Hengrui Pharmaceuticals, Jnana Therapeutics, John Hopkins University School of Medicines, Johns Hopkins University, Johnson & Johnson, Johnson & Johnson Innovation, JSR Life Sciences, Jubilant Biosys, Jubilant Therapeutics, Junshi Biosciences, Jura Bio, Juvenile Diabetes Research Foundation, JW Therapeutics, Kadimastem, Kadmon Pharmaceuticals, Kahn-Sagol-Maccabi, Kainos Medicines, Kaken Pharmaceutical, KaliVir Immunotherapeutics, Kallyope, KangaBio, Kansas State University, Kantonsspital St. Gallen, Kanyr Pharma, Karolinska Institute, Karuna Therapeutics, KBio, KeifeRx, Keio Gijuku University, Kelonia Therapeutics, KELTIC Pharma, Kelun-Biotech Biopharmaceutical, Kennedy Institute of Rheumatology, kENUP Foundation, Kermode Biotechnologies, Kimer Med, Kings College London, KinoPharma, Kiromic Biopharma, Kite Pharma, Kiyatec, Kleo Pharmaceuticals, Knopp Biosciences, Kobe University, Kodiak Sciences, Korro Bio, Kriya Therapeutics, Kronos Bio, KSQ Therapeutics, KTH Royal Institute of Technology, Kumquat Biosciences, Kures, Kvantify, Kymera Therapeutics, Kyowa Hakko Kirin, Kyowa Hakko Kirin Pharmaceuticals, Kytopen, Kyttaro, Kyushu University, Kyverna Therapeutics, LabGenius, Laboratory Corporation of America, Lacerta Therapeutics, La Jolla Institute for Allergy & Immunology, La Jolla Labs, Landmark Bio, Lantern Pharma, Lassen Therapeutics, Latham BioPharm Group, Lava Therapeutics, Laxai Pharma, Laxxon Medical, Lead Pharma, Lee Moffitt Cancer Center, Legend Biotech, LegoChem Biosciences, Leiden University, Leidos, Lenovo, LEO Pharma, Lesaffre, Les Laboratoires Servier, Leucid Bio, Leukemia & Lymphoma Society, LeukoCom, Leveragen, LEXEO Therapeutics, LG Life Sciences, LianBio, Libera Bio, LiberoThera, Lieber Institute, LifeArc, Life Edit Therapeutics, LifeMine Therapeutics, LIfT BioSciences, LigaChem Biosciences, Ligand Pharmaceuticals, Light Chain Bioscience, Light Horse Therapeutics, Liminal BioSciences, LimmaTech Biologics, Lineage Cell Therapeutics, LinkBio, LinKinVax, Linus Biotechnology, Lion TCR, Lipidomics Consulting, Lipigon Pharmaceuticals, Liquid Biosciences, LiteVax, Lixte Biotechnology, LMU University Hospital Munich, LogicBio Therapeutics, LogicInk, Logomix, Long Island University, Longwood University, Lonza, LoQus23 Therapeutics, Loulou Foundation, Loxo Oncology, LUCA Science, Lucidam, Lucid Psycheceuticals, Lucy Therapeutics, LumaBridge, Lumen Biomedical, Luminary Therapeutics, LUNAC Therapeutics, Lunaphore, Lundbeck, Lundquist Institute, Lund University, Lung Cancer Research Foundation, LUNGevity Foundation, Lupus Research Alliance, Lupus Therapeutics, Lurie Children's Hospital of Chicago, Luxna Biotech, Lycia Therapeutics, Lyell Immunopharma, LyGenesis, Lynk Pharmaceuticals, Lysando, Lysogene, Lytica Therapeutics, M2Gen, Mablink Bioscience, MAbSilico, Mabwell Bioscience, Mabylon, Macau University of Science and Technology, Macomics, Macrogen, Macrogenics, Macromoltek, Magdalena Biosciences, Magle Chemoswed, Magnetrap, Mainz University Medical Centre, MAKScientific, Mammoth Biosciences, Manhattan BioSolutions, Mannin Research, MapLight Therapeutics, Marengo Therapeutics, Marinus Pharmaceuticals, Mark Foundation for Cancer Research, Massachusetts General Hospital, Massachusetts Institute of Technology, Massachusetts Life Sciences Center, Mass General Brigham, Massive Bio, Matica Biotechnology, Matinas Biopharma, Max-Planck, Max Biopharma, Maxcyte, Maxion Therapeutics, Max Planck Institute for Multidisciplinary Sciences, MaxScientific, Mayo Clinic, Maze Therapeutics, McGill University, McQuade Center for Strategic Research and Development, mCureX Therapeutics, MD Anderson Cancer Center, MDimune, Mediar Therapeutics, Medical College of Wisconsin, Medical Research Council, Medical Research Futures Fund, Medical University of Graz, Medical University of Vienna, Medical University South Carolina, MediciNova, MEDiC Life Sciences, Medicure, Medidata Solutions, MediGene, Medigen Vaccine Biologics, MediLink Therapeutics, Medipal Holdings, MediSix Therapeutics, Medison Pharma, Medivir, MedPacto, MedRhythms, Medtronic, Meharry Medical College, Meiogenix, Mekonos, Mellow Hope Bio Chem, Memorial Sloan Kettering Cancer Center, Memo Therapeutics, MemVerge, Menarini, Menten AI, MercachemSyncom, Merck and Co, Merck Animal Health, Merck KGaA, Merck Sharpe & Dohme, Merdury Biopharmaceutical, Mersana Therapeutics, Merus, Mestag Therapeutics, Metabolon, Metagenomi, Metis Therapeutics, Metrion Biosciences, MGFB, Michael J Fox Foundation, Michelson Center, Microbiotix, Microsoft, Mid-Atlantic BioTherapeutics, Mie University, MIGAL Galilee Research Institute, MILA International, MilliporeSigma, MiMedx, Mimetas, MiNA Therapeutics, MindRank AI, Minerva Biotechnologies, MiNK Therapeutics, Minovia Therapeutics, Miralogx, miRecule, Mirimus, Mirus Bio, Mission Bio, Mission Cure, Mission Therapeutics, Mitacs, Mitobridge, MitoCanada Foundation, Mitochondrial Innovation Initiative, MitoSense, Mitsubishi Tanabe Pharma, MOBILion Systems, Modag, Modalis Therapeutics, Model Medicines, Moderna, ModeX Therapeutics, Modifi Bio, Mohammed VI Polytechnic University, Molcure, Molecular Assemblies, Molecular Health, Molecular Partners, Molecular Templates, Molecule, Molecule.one, Molecure, MOMA Therapeutics, Monash University, Montefiore Health System, Monte Rosa Therapeutics, Montreal Neurological Institute-Hospital, Morningside Ventures, Morphic Therapeutic, Mor Research Applications, Mosaic Biosciences, Mosaic ImmunoEngineering, Moss Genomics, Mount Sinai Health System, MPM Capital, MRM Health, MSD, Multimmune, Multiple Myeloma Research Foundation, Multiple Sclerosis Society of Canada, Muna Therapeutics, Muscular Dystrophy Association, Mustang Bio, MyBiotics Pharma, My Care Express Merrillville, Mydecine Group, Myeloid Therapeutics, Mymetics, MYND Life Sciences, myNEO, MyoKardia, Myricx Bio, Myrtelle, Mythic Therapeutics, n-Lorem Foundation, Nagoya University Graduate School of Medicine, Namocell, Nanite, Nanjing Leads Biolabs, Nanna Therapeutics, NanoCellect Biomedica, Nanoform, Nanommune, NanoString Technologies, NanoTemper Technologies, NaNotics, NanoVation Therapeutics, Nantes University, NantKwest, NantOmics, Nashville Biosciences, Natera, National Cancer Center of Japan, National Cancer Institute, National Center for Advancing Translational Sciences (NCATS), National Centre for Research and Development, National Comprehensive Cancer Network (NCCN), National Eye Institute, National Health Service, National Heart, Lung and Blood Institute, National Human Genome Research Institute, National Institute for Bioprocessing Research and Training, National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development, National Institute of Dental and Craniofacial Research (NIDCR), National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of General Medical Sciences, National Institute of Infectious Diseases, National Institute of Mental Health, National Institute of Neurological Disorders and Stroke, National Institute of Standards and Technology, National Institute on Aging, National Institutes of Biomedical Innovation, Health and Nutrition, National Institutes of Health, National Organization for Rare Disorders, National Research and Innovation Agency of Uruguay, National Research Council Canada, National Research Council of Canada, National Science Foundation, National University of Ireland, Galway (NUI Galway), National University of Singapore, Nationwide Children’s Hospital, Nature Technology, Nautilus Biotech, Navigo Proteins, Navinci Diagnostics, Navrogen, NBE Therapeutics, Ncardia, Nektar Therapeutics, Neochromosome, NeoCura Bio-Medical Technology, Neogap Therapeutics, Neo Gene Pharm, Neogene Therapeutics, Neogenomics, NeoImmuneTech, Neomorph, NeoPhore, Neosoma, NeoX Biotech, Nerviano Medical Sciences, Nested Therapeutics, Netherlands Cancer Institute, NetraMark, NETRIS Pharma, NeuBase Therapeutics, NeuCyte, Neukio Biotherapeutics, Neumora Therapeutics, Neurimmune Therapeutics, Neuro3 Therapeutics, Neurocrine Biosciences, Neurodon, Neurogene, NeuroLucent, Neurophth Therapeutics, Neuropore Therapies, Neuvogen, NewBiologix, Newcastle University, New England Biolabs, New Wave Ventures, Nexilico, Neximmune, Next Gen Diagnostics, NextVivo, NGM Biopharmaceuticals, Nilogen Oncosystems, Nimble Therapeutics, Nimbus Therapeutics, NIMIUM Therapeutics, NIMML Institute, NImmune Biopharma, Nippon Shinyaku, Nirogy Therapeutics, NJ Bio, Nkarta Therapeutics, NMI Natural and Medical Sciences Institute, Noachis Terra, Noga Therapeutics, Noile-Immune Biotech, Nona Biosciences, NonExomics, Nordic Nanovector, Normunity, North Carolina State University, North Med, Northwestern University, Nostrum Biodiscovery, Notable Labs, NovAliX, Novartis, Novavax, Novellus Biopharma, Novellus Therapeutics, Novocure, Novogene, Novome Biotechnologies, Novo Nordisk, Noxopharm, Nrgene, NRG Therapeutics, NTx, Nucleai, NuclixBio, NuGenerex Immuno-Oncology, Numab, Nuntius Therapeutics, Nurix Therapeutics, Nurosene, Nusano, Nuvisan Pharma Services, Nvidia, NWO.ai, Nxera Pharma, Nykode Therapeutics, NysnoBio, NYU Langone Medical Center, Oak Ridge National Laboratory, Oblique Therapeutics, Obsidian Therapeutics, Ocean Biomedical, Octagon Research Solutions, Ocular Therapeutix, Ocumension Therapeutics, Odyssey Therapeutics, Ohio State University, Oklahoma Medical Research Foundation, Olaris, Olema Oncology, Olink Proteomics, OliPass, Olivia Newton-John Cancer Research Institute, OliX Pharmaceuticals, Olon, Omega Therapeutics, OmniAb, OmniaBio, Omniose, OmniSpirant, Ona Therapeutics, OncoArendi Therapeutics, Oncocross, Oncode Institute, Oncodesign, OncoDNA, Oncogenuity, Oncoheroes Biosciences, OncoHost, Oncologie, Oncology Pharma, OncoMyx Therapeutics, OncoNano Medicine, Oncorus, Oncotelic, Oncovir, Oncozen, Oncternal Therapeutics, One Mind for Research, OneThree Biotech, ONI, oNKo-innate, ONK Therapeutics, Ono Pharmaceutical, Ontario Institute for Cancer Research, Ontario Institute for Regenerative Medicine, Ontochem, Onward Therapeutics, OpenAI, OpenBench, OpenEye Scientific Software, OpenFold Drug Discovery AI Research Consortium, OPKO Health, Opsis Therapeutics, Optibrium, Optieum Biotechnologies, Oragenics, Orange Grove Bio, Orano Med, Orbis Medicines, Orbit Discovery, Orca Bio, Orchard Therapeutics, Ordaos Bio, Oregon Health Sciences University, Orexia Therapeutics, Organo Therapeutics, ORIC Pharmaceuticals, OrigiMed, Orion, Orion Genomics, Orionis Biosciences, Orna Therapeutics, OrsoBio, Orum Therapeutics, Oryzon, Oscotec, OSE Immunotherapeutics, Oslo University Hospital, Ospedale Pediatrico Bambino Gesu, Ossium Health, Ostentus Therapeutics, Otsuka, Outpace Bio, Ovation, Overland Pharmaceuticals, Ovid Therapeutics, Owkin, Oxford Biodynamics, Oxford BioMedica, Oxford BioTherapeutics, Oxford Drug Design, Oxford Nanopore Technologies, Oxgene, Oyster Point Pharma, Pacific Biosciences, PACT Pharma, Palantir, panCELLa, Pandion Therapeutics, Pangu BioPharma, Pantherna Therapeutics, Papyrus Therapeutics, PAQ Therapeutics, Paragon Therapeutics, Paraza Pharma, Parent Project Muscular Dystrophy, Parexel, Parkinson's Disease Foundation, Parkinson's UK, Parthenon Therapeutics, Pasithea Therapeutics, PathAI, Path BioAnalytics, PatientsLikeMe, Pearl Bio, Peking Union Medical College, Penn State Cancer Institute, Penn State Microbiome Center, Pennsylvania Biotechnology Center, PentixaPharm, Pepscan, PeptiDream, Peptilogics, Persephone Biosciences, Personal Genome Diagnostics, Personalis, Peter Doherty Institute for Infection and Immunity, Peter MacCallum Cancer Institute, Pfizer, PGI Drug Discovery, Phanes Therapeutics, PharmAbcine, Pharmacelera, PharmaEssentia, PharmAI, PharmaJet, PharmaTher, PharmEnable, Pharming Group, Pharmsynthez, Phase Genomics, PHAXIAM Therapeutics, Phenomic AI, PhenoVista Biosciences, Pheon Therapeutics, Philips, Philochem, Philogen, Phio Pharmaceuticals, Phlox Therapeutics, Phoenix PharmaLabs, PhoreMost, PhotonPharma, PhysIQ, PicnicHealth, Pieris Pharmaceuticals, Pierre Fabre, PineTree Therapeutics, Pionyr Immunotherapeutics, Plantae Biosciences, Plexium, Plex Research, Pluristem Therapeutics, Pluristyx, POINT Biopharma, PolarisQB, Politecnico University, Portal Bioscience, Poseida Therapeutics, PostEra, Pragma Bio, Praxis Precision Medicines, Precision BioSciences, PrecisionLife, Precision NanoSystems, Precision Virologics, Predictive Oncology, Preferred Networks, Prellis Biologics, Prelude Therapeutics, Premas Biotech, Prevail Therapeutics, Prevencio, Prime Medicine, Primordial Genetics, Princeton University, PRISM BioLab, ProBioGen, Probius, ProfoundBio, ProFound Therapeutics, Project ALS, ProMab Biotechnologies, Prometheus Biosciences, ProQinase, ProQR Therapeutics, Proteic Bioscience, ProteinQure, ProteinTech, Protelica, Proteona, Proteovant Therapeutics, Proteros biostructures, ProThera, Provention Bio, Providence Therapeutics, PROVIREX Genome Editing Therapies, Proxygen, PsyBio Therapeutics, PsychoGenics, PTC Therapeutics, Pulmatrix, Pulmonary Fibrosis Foundation (PFF), Purdue Research Foundation, Purdue University, Pure Biologics, Purespring Therapeutics, Purnovate, Purple Biotech, QDX, QIAGEN, Qilu Pharmaceutical, Qinotto, Quadira Biosciences, Quadram Institute, Qualigen, Quanterix, Quantoom Biosciences, Quebec Consortium for Drug Discovery, Queen Mary University of London, Queensland Institute of Medical Research (QIMR), Queensland University of Technology, Queens University Belfast, Quell Therapeutics, Quercis Pharma, Quoin Pharmaceuticals, QureTech Bio, R4D Biotech, rAAVen Therapeutics, Radboud University Nijmegen, Radiance Biopharma, Radionetics Oncology, Rady Children's Institute for Genomic Medicine, Ragon Institute, Rain Oncology, Rakovina Therapeutics, Rakuten Medical, Rallybio, Ramot at Tel Aviv University, Ranok Therapeutics, RARE-X, Rarebase, Rational Vaccines, RayzeBio, Realm IDx, Rebus Biosystems, ReCode Therapeutics, Recombia Biosciences, Recombinetics, Recursion, Redbiotec, Redwire, Redx Pharma, RefleXion Medical, Refuge Biotechnologies, Regen BioPharma, Regencell Bioscience, Regeneron Pharmaceuticals, RegenLab, Regenxbio, Regional Cancer Institute of Montpellier, Reglagene, Regor Therapeutics, ReiThera, Related Sciences, Relation Therapeutics, Relief Therapeutics, Remix Therapeutics, RenalytixAI, Renato Dulbecco Foundation, RenBio, Repare Therapeutics, Repertoire Immune Medicines, Replay, Replica Analytics, Replicate Bioscience, Replicel Life Sciences, Repurpose.AI, Res Nova Bio, RespireRx Pharmaceuticals, RetinAI Medical, Revelation Biosciences, Reverie Labs, ReviR Therapeutics, Revitope Oncology, ReviveMed, Revive Therapeutics, RevolKa, Revolution Medicines, Revvity, Reyon Pharmaceuticals, Rgenta Therapeutics, Rheos Medicines, Ribometrix, Rice University, Riffyn, Rigel Pharmaceuticals, Rigshospitalet, RIKEN Research Institute, RION, RNAGene, Roche, Roche Diagnostics, Rockefeller University, Rocket Science Health, RockStep Solutions, Roivant Sciences, Rona Therapeutics, Rondo Therapeutics, RoosterBio, Rosalind, Rosalind Franklin University of Medical Sciences, Rosetta Biosciences, RosVivo Therapeutics, Roswell Biotechnologies, Roswell Park Cancer Institute, Rothamsted Research, Roux Institute, RQ Biotechnology, Rubedo Life Sciences, RubrYc Therapeutics, Rutgers University, RxCell, Ryvu Therapeutics, Rznomics, SAB Biotherapeutics, Saccharo, Sage Bionetworks, Saint-Gobain Life Sciences, SalioGen Therapeutics, Salipro Biotech, Salk Institute, Sana Biotechnology, SanBio, SanegeneBio, Sanford Burnham Institute, Sangamo Therapeutics, Saniona, Sanofi, Sanofi-Pasteur, Santa Cruz Biotechnology, Sanyou Biopharmaceuticals, Saphetor, SaponiQx, Sapphire Biotech, Sarcomatrix Therapeutics, Sarepta Therapeutics, Satellos Bioscience, SaudiVax, Scailyte, Scenic Biotech, Scholar Rock, Schrodinger, Science for Life Laboratory, SciNeuro Pharmaceuticals, Scipher Medicine, SciSparc, Sciwind Biosciences, Scorpion Therapeutics, Scottish Enterprise, Scribe Therapeutics, Scripps Research Institute, Scriptr Global, Seagen, Seattle Children's Hospital, Seattle Children's Therapeutics, Seattle Childrens Research Institute, Seattle Genetics, Secarna Pharmaceuticals, Second Genome, Sedec Therapeutics, Seed Therapeutics, Seismic Bio, Seismic Therapeutic, Selagine, Selecta Biosciences, Selexis, Selonterra, Selvita, Sema4, SemaThera, Seneca Therapeutics, Sengenics, SEngine Precision Medicine, Sentia Medical Sciences, Senti Biosciences, Seoul National University, Septerna, Seqirus, Sequence Bio, Seragon Pharmaceuticals, SeraNovo, Sernova, Serotiny, Serum Institute of India, Seven Bridges Genomics, Sexton Biotechnologies, Shanghai Affinity Biopharmaceutical, Shanghai Cell Therapy Group, Shanghai Pharmaceutical, Shanghai ZhenGe Biotechnology, Shape Therapeutics, Shasqi, Shattuck Labs, Sheba Medical Center, Shepherd Therapeutics, Sherlock Biosciences, Shimadzu, Shionogi, Shionogi Pharma, Shoreline Biosciences, Sibylla Biotech, Sigilon Therapeutics, Signet Therapeutics, SilcsBio, Silence Therapeutics, Silexon, Simcere Pharmaceuticals, Simnova, Simulations Plus, Sinclair Research, Singapore Eye Research Institute (SERI), Singapore Sengkang General Hospital, Singlera Genomics, Singleron Biotechnologies, Singular Genomics Systems, Singzyme, Sino-American Cancer Foundation, Sino Biological, SinoMab Bioscience, Sinorda Biomedicine, Siolta Therapeutics, Sirion Biotech, Sirnaomics, Sirona Biochem, Sirona Dx, Sironax, SiSaf, Siteman Cancer Center, SiteOne Therapeutics, Sitryx, SK Biopharmaceuticals, SK Bioscience, SK Chemicals, Skip Therapeutics, Skyhawk Therapeutics, Skyline Therapeutics, Skysong Innovations, Smart Immune, SmartPharm Therapeutics, Soleno Therapeutics, Solid Biosciences, Soligenix, Solve Therapeutics, SomaLogic, Sonoma BioTherapeutics, Sony, SOPHiA Genetics, Sorrento Therapeutics, Sosei, Sosei Heptares, SOTIO, Southwest Research Institute, Spanios, Spanish National Cancer Research Centre, SparingVision, Spark Therapeutics, Specifica, Spindle Biotech, SpliceBio, SpringWorks Therapeutics, Sprint Biosciences, SPT Labtech, SpyBiotech, SRI International, St. Baldrick's Foundation, St. Jude Children's Research Hospital, Stallargenes, Stallergenes Greer, Standigm, Stand Up To Cancer, Stanford University, Stanford University School of Medicine, Starget Pharma, Starpharma, Stavros Niarchos Foundation, STC Biologics, Stem Genomics, Stemline Therapeutics, StemoniX, Stem Pharm, StemSight, Step Pharma, SteroTherapeutics, Stoke Therapeutics, Stony Brook University, Storm Therapeutics, Strand Therapeutics, StrideBio, Structural Genomics Consortium, Strykagen, Sumaya Biotech, Sumitomo Dainippon Pharma, Sumitomo Mitsui Banking Corporation, Sumitovant Biopharma, Sunnybrook Research Institute, Sun Pharma Advanced Research Company, SunRock Biopharma, Sunshine Biopharma, Sun Yat-sen University, Supercell Biotechnology, Surface Oncology, Surrogen, Surrozen, Susan G. Komen for the Cure, Sutro Biopharma, Suzhou Porton Advanced Solutions, Suzhou Ribo Life Sciences, SwanBio Therapeutics, Swift Biosciences, Sybleu, Syena, Sygnature Discovery, Symbasis, Symphogen, Symvivo, Synaffix, Synbal, Syncromune, Synedgen, SynerK, Syngene International, Syngenta, Synlogic, Syntekabio, Synthego, Synthekine, SyntheticGestalt, SyntheX, Syracuse Biopharma, Systems Oncology, T-Cure Bioscience, Tachyon Therapeutics, Taiho, Taisho Pharmaceutical, Takara Bio, Takeda Oncology, Takeda Pharmaceutical, Takeda Ventures, Talem Therapeutics, Tallac Therapeutics, Talus Bioscience, Tanabe Research Laboratories, Tantu Therapeutics, TARA Biosystems, Targovax, Tavotek Biotherapeutics, Tavros Therapeutics, Taysha Gene Therapies, TB Alliance, TC BioPharm, TCGFB, TCR2 Therapeutics, Tegmine Therapeutics, Teijin, Tella, Telomir Pharmaceuticals, Tempus, Ten63 Therapeutics, TeneoBio, TenNor Therapeutics, Tentarix Biotherapeutics, Terran Biosciences, Terray Therapeutics, Terumo Blood and Cell Technologies, Tesis Biosciences, Tessera Therapeutics, Tetra Bio-Pharma, Tetra Pharm Technologies, Teva Pharmaceutical Industries, Tevard Biosciences, Texas A&M Health Science Center, Texas A&M University, Texas Heart Institute, TFC Therapeutics, The International AIDS Vaccine Initiative, The Medical Research, Infrastructure, and Health Services Fund of the Tel Aviv Medical Center, The New York Stem Cell Foundation, The Parker Institute For Cancer Immunotherapy, Theragen, Theralink Technologies, TheraPanacea, Therapeutic Solutions International, Thermo Fisher Scientific, Theseus Pharmaceuticals, ThinkCyte, ThinkingNodeLife, Thoeris, Thorne HealthTech, Three Lakes Foundation, Thylacine Biotherapeutics, Tianjin CanSino Biotechnology, Tianjin University, Tiba Biotech, Titan Pharmaceuticals, TiumBio, T Med, Tokyo Medical and Dental University, Tolo Biotech, TONIX Pharmaceuticals, Toolgen, Toronto Centre for Psychedelic Science, Tor Vergata University Hospital, Total Brain, Totient, Totus Medicines, Touchlight, TransCelerate BioPharma, TransCode Therapeutics, Translate Bio, Translational Genomics Research Institute, TransThera, Traverse Biosciences, Treadwell Therapeutics, Treventis, TRexBio, TRIANA Biomedicines, Trianni, Trinity College Dublin, Trinomab Biotech, Triumvira Immunologics, TRT Innovations, TrueBinding, Trutino Biosciences, TScan Therapeutics, Tubulis, Tufts University, TuHURA Biopharma, TuHURA Biosciences, TumorGen, TumorGenesis, Turbine, Turn Biotechnologies, Turnstone Biologics, Turn Therapeutics, Twinstrand Therapeutics, Twist Bioscience, Tyris Therapeutics, Ubiquigent, Ubix Therapeutics, UCB, UCL Business, Ultivue, Ultragenyx Pharmaceuticals, Umoja Biopharma, Uni-Bio Science, UniQuest, UniQure, Unison Medicines, United Immunity, Univercells, Univeristy of Durham, Universal Cells, University College London, University Gottingen, University Health Network, University Hospital Heidelberg, University Hospital Jena, University Libre of Brussels, University Medical Center Groningen, University of Aberdeen, University of Alabama at Birmingham, University of Amsterdam, University of Arizona, University of Barcelona, University of Basel, University of Bath, University of British Columbia, University of Buffalo, University of Calgary, University of California, Davis, University of California, San Diego, University of California Berkeley, University of California Irvine, University of California Los Angeles, University of California San Francisco, University of California Santa Barbara, University of Central Florida Research Foundation, University of Chicago, University of Cincinnati, University of Colorado, University of Connecticut, University of Copenhagen, University of Dundee, University of Edinburgh, University of Florida, University of Geneva, University of Georgia, University of Glasgow, University of Hawaii, University of Helsinki, University of Hong Kong, University of Houston, University of Illinois at Chicago, University of Iowa, University of Lausanne, University of Lethbridge, University of Ljubljana, University of Louisville, University of L’Aquila, University of Manchester, University of Marburg, University of Maryland, University of Maryland Baltimore, University of Maryland School of Medicine, University of Massachusetts, University of Massachusetts Medical School, University of Melbourne, University of Miami, University of Michigan, University of Minnesota, University of Missouri, University of Montreal, University of New South Wales, University of North Carolina, University of Notre of Dame, University of Oslo, University of Oxford, University of Pennsylvania, University of Pittsburgh, University of Saskatchewan, University of Sheffield, University of South Australia, University of Southern California, University of Southern Denmark, University of Sydney, University of Technology Sydney, University of Texas, University of Texas Health SCience Center at San Antonio, University of Texas Medical Branch, University of Texas Southwestern Medical Center, University of the Witwatersrand, University of Toronto, University of Tsukuba, University of Tubingen, University of Tulsa, University of Utah, University of Vermont, University of Virginia, University of Washington, University of West Indies, University of Wisconsin, University of Wisconsin-Madison, University of Wollongong, University of Wurzburg, University of Zurich, Unravel Biosciences, Unum Therapeutics, Uorsy, Upadia, Uppsala University, Uppthera, USANA Health Science, US Army Medical Research and Material Command, US Army Medical Research Institute of Chemical Defense, US Army Medical Research Institute of Infectious Diseases, US Government, Usynova Pharmaceuticals, Utrecht University, UT Southwestern Medical Center, UWM Research Foundation, Vaccinex, Valence Discovery, Vall d’Hebron Research Institute, Valo Health, Valo Therapeutics, Van Andel Institute, Vanda Pharmaceuticals, Vanderbilt University, VantAI, Variant Bio, Variational AI, Vaxalto Biotherapeutics, VaxEquity, Vaxil BioTherapeutics, VaxThera, Vaxxinity, VBI Vaccines, Vector Laboratories, VectorY Therapeutics, Vectura, Velabs Therapeutics, VenatoRx, Veneno Technologies, Venturis Therapeutics, Ventus Therapeutics, Veracyte, Verana Health, Veranome Biosystems, Verantos, Verastem, Veraxa Biotech, Verge Genomics, Verily, VerImmune, VeriSIM Life, Verismo Therapeutics, Vernalis, Versatope Therapeutics, Verseau Therapeutics, Vertex Pharmaceuticals, Verve Therapeutics, Vesalius Therapeutics, Vetigenics, Vetophage, VIB, Vibliome Therapeutics, Vibrent Health, Victoria University, VieCure, Viewpoint Molecular Targeting, ViGeneron, ViiV Healthcare, Vincere Biosciences, Vinnova, Vipergen, Viravaxx, Vir Biotechnology, Virginia Commonwealth University, Virginia Polytechnic Institute and State University, Virion Therapeutics, Virogen, Vittoria Biotherapeutics, Vituity, Viva Biotech, Vividion Therapeutics, Vivlion, vivoPharm, Vivtex, Volastra Therapeutics, Voltron Therapeutics, Vor Biopharma, Voronoi, Voyager Therapeutics, Vuja De Sciences, Vyant Bio, Vycellix, VYNE Therapeutics, Vyriad, Wageningen University, Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Walking Fish Therapeutics, Washington University in St Louis, WaVe Lifesciences, WAVE Life Sciences, Weatherden, Weill Cornell Medical College, Weizmann Institute, Wellcome Trust Sanger Institute, Wellmarker Bio, Western Digital, Westlake Pharma, Wheeler Bio, Whitehead Institute, WhiteLab Genomics, Willow Biosciences, Wisconsin Alumni Research Foundation, Wiseman Cancer Research Foundation, Wistar Institute, Wolverine Foundation, Wonkwang University, Wren Therapeutics, WUGEN, WuXi Biologics, WuXi XDC, Wyss Institute, X-chem, Xanadu, Xcellomics, Xencor, Xenetic Biosciences, Xilio Therapeutics, Xilis, Ximbio, Xlife Sciences, Xoma, XtalPi, Xylyx Bio, Xyphos Biosciences, Y-Biologics, Y-mAbs Therapeutics, Yale Cancer Center, Yale University, YASKAWA Electric, Yatiri Bio, Yeda Research and Development Company, Yield10 Bioscience, Yissum Research Development, Yiviva, Ymir Genomics, Ymmunobio, Yufan Biotechnologies, YUMAB, Yumanity Therapeutics, ZabBio, ZAI Laboratory, ZebiAI Therapeutics, ZeClinics, Zelluna Immunotherapy, Zentalis Pharmaceuticals, Zephyr AI, ZERO Childhood Cancer, Zhejiang Doer Biotechnology, Zoetis, Zogenix, ZS Pharma, Zydus Cadila, Zymeworks, ZYUS Life Sciences

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• CRADA
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.